RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.17
+0.00 (+0.00%)
Analyst Consensus
Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+811.7% upside
Low Target
$21.05
Average Target
$28.90
High Target
$39.88
Current Price
$3.17
Current
$3.17
$3.17
Target
$28.90
$28.90
$21.05
$28.90 avg
$39.88
Scenario Analysis
Bear Case
$21.05
564.0%
Low target
Base Case
$28.90
+811.7%
Avg target
Bull Case
$39.88
+1,158.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$7.18
-55.8% from high
52-Week Low
$2.98
+6.4% from low
50-Day SMA
$4.31
-26.5% vs SMA
200-Day SMA
$4.89
-35.2% vs SMA
RSI (14)
34.7
Neutral
Target vs 52W High
$28.90
+302.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +22.0% |
| AMGN | Hold | 42 | 50% | $190.87 | -45.9% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +163.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.9% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.9% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -69.2% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |